Medicare Enrolled
Dr. Mourad Abdelmessih, M.D
Optician · Newark, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Abdelmessih from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abdelmessih?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Abdelmessih
Dr. Mourad Abdelmessih is an optician specialist in Newark, OH, with 21 years of NPI registration. Based on federal Medicare data, Dr. Abdelmessih performed 1,052 Medicare services across 545 unique beneficiaries.
Between the years covered by Open Payments, Dr. Abdelmessih received a total of $36,913 from 99 pharmaceutical and/or device companies across 1557 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Abdelmessih is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 35% volume in OH
$36,913 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,052
Medicare services
Top 35% in OH for optician
545
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~50 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
686 | $82 | $234 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
87 | $9 | $32 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
85 | $1 | $3 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
67 | $115 | $355 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
30 | $63 | $160 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
29 | $260 | $757 |
| New patient office visit, complex (60-74 min) | 28 | $155 | $446 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
28 | $122 | $314 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
12 | $87 | $272 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$36,913
Total received (2018-2024)
Avg $5,273/year across 7 years
Top 7% in OH for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
99
Companies
1,557
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$28,570 (77.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,343 (22.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,185
2023
$4,521
2022
$3,392
2021
$8,563
2020
$5,233
2019
$5,102
2018
$5,919
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$457
Sumitomo Pharma America, Inc.
$354
Lilly USA, LLC
$339
Neurelis, Inc.
$274
Eisai Inc.
$218
PFIZER INC.
$214
Lundbeck LLC
$187
CATALYST PHARMACEUTICALS, INC.
$172
EMD Serono, Inc.
$162
UCB, Inc.
$154
JAZZ PHARMACEUTICALS INC.
$146
ANI Pharmaceuticals, Inc.
$142
Genentech USA, Inc.
$137
Teva Pharmaceuticals USA, Inc.
$126
Biogen, Inc.
$116
Otsuka America Pharmaceutical, Inc.
$103
TG Therapeutics, Inc.
$94
ACADIA Pharmaceuticals Inc
$93
SK Life Science, Inc.
$77
Kyowa Kirin, Inc.
$76
Amneal Pharmaceuticals LLC
$63
Mallinckrodt Hospital Products Inc.
$62
CSL Behring
$55
Currax Pharmaceuticals LLC
$46
Alexion Pharmaceuticals, Inc.
$44
Celgene Corporation
$36
Takeda Pharmaceuticals U.S.A., Inc.
$34
Axsome Therapeutics, Inc.
$31
Tonix Medicines, Inc.
$31
Acorda Therapeutics, Inc
$22
Neurocrine Biosciences, Inc.
$22
Medtronic, Inc.
$19
Amgen Inc.
$17
MDD US Operations, LLC
$16
Abbott Laboratories
$16
Merz Pharmaceuticals, LLC
$15
MITSUBISHI TANABE PHARMA AMERICA, INC.
$15
Top 3 companies account for 27.5% of 2024 payments
All-time payments by company (2018-2024) ›
Biohaven Pharmaceuticals, Inc.
$7,737
Novartis Pharmaceuticals Corporation
$2,519
UCB, Inc.
$1,200
EMD Serono, Inc.
$1,152
Biogen, Inc.
$1,122
Eisai Inc.
$1,098
Teva Pharmaceuticals USA, Inc.
$1,047
Abbott Laboratories
$965
Sumitomo Pharma America, Inc.
$857
Lilly USA, LLC
$850
Lundbeck LLC
$804
Amgen Inc.
$790
Supernus Pharmaceuticals, Inc.
$759
ABBVIE INC.
$731
ACADIA Pharmaceuticals Inc
$683
CSL Behring
$680
Genentech USA, Inc.
$677
AbbVie Inc.
$644
Neurocrine Biosciences, Inc.
$545
PFIZER INC.
$509
Alexion Pharmaceuticals, Inc.
$499
Celgene Corporation
$498
Neurelis, Inc.
$480
Sunovion Pharmaceuticals Inc.
$415
Otsuka America Pharmaceutical, Inc.
$393
LivaNova USA, Inc.
$390
Amneal Pharmaceuticals LLC
$389
Kyowa Kirin, Inc.
$366
Assertio Therapeutics, Inc.
$331
Janssen Pharmaceuticals, Inc
$324
SK Life Science, Inc.
$323
Acorda Therapeutics, Inc
$312
Biohaven Pharmaceutical Holding Company Ltd.
$294
Allergan, Inc.
$289
Avanir Pharmaceuticals, Inc.
$286
Adamas Pharmaceuticals, Inc.
$279
BANNER LIFE SCIENCES, LLC
$260
GENZYME CORPORATION
$257
Horizon Therapeutics plc
$238
IMPEL PHARMACEUTICALS INC.
$201
JAZZ PHARMACEUTICALS INC.
$201
Greenwich Biosciences, Inc.
$197
CATALYST PHARMACEUTICALS, INC.
$186
Currax Pharmaceuticals LLC
$185
AbbVie, Inc.
$183
EISAI INC.
$182
Mallinckrodt Hospital Products Inc.
$174
Mitsubishi Tanabe Pharma America, Inc.
$171
Allergan Inc.
$164
Alnylam Pharmaceuticals Inc.
$156
Merz North America, Inc.
$145
ANI Pharmaceuticals, Inc.
$142
Avion Pharmaceuticals
$123
ARGENX US, INC.
$115
Mallinckrodt Enterprises LLC
$111
Dynasplint Systems Inc.
$97
Upsher-Smith Laboratories LLC
$95
TG Therapeutics, Inc.
$94
UPSHER-SMITH LABORATORIES LLC
$94
Merz Pharmaceuticals, LLC
$90
Ipsen Biopharmaceuticals, Inc
$88
ARBOR PHARMACEUTICALS, INC.
$88
MERZ NORTH AMERICA, INC.
$85
TG THERAPEUTICS, INC.
$81
Promius Pharma LLC
$81
Catalyst Pharmaceuticals, Inc.
$80
US WorldMeds, LLC
$80
E.R. Squibb & Sons, L.L.C.
$79
Egalet US Inc
$79
Impax Laboratories, Inc.
$76
Axsome Therapeutics, Inc.
$71
Mallinckrodt LLC
$65
Zyla Life Sciences
$65
NATUS MEDICAL INCORPORATED
$64
Bayer HealthCare Pharmaceuticals Inc.
$59
Jazz Pharmaceuticals Inc.
$59
Vertical Pharmaceuticals, LLC
$54
MITSUBISHI TANABE PHARMA AMERICA, INC.
$53
Alfasigma USA, Inc.
$40
Medtronic USA, Inc.
$37
Scilex Pharmaceuticals Inc.
$36
Takeda Pharmaceuticals U.S.A., Inc.
$34
Medtronic, Inc.
$34
Merck Sharp & Dohme Corporation
$32
Almatica Pharma LLC
$32
Tonix Medicines, Inc.
$31
Amylyx Pharmaceuticals, Inc.
$24
Banner Life Sciences, LLC
$24
GE HEALTHCARE
$23
Mylan Pharmaceuticals Inc.
$21
Cala Health, Inc.
$19
SANOFI-AVENTIS U.S. LLC
$18
Aprecia Pharmaceuticals, LLC
$17
MDD US Operations, LLC
$16
Grifols USA, LLC
$16
Collegium Pharmaceutical, Inc.
$15
Daiichi Sankyo Inc.
$15
Zyla Life Sciences, Inc.
$14
Endo Pharmaceuticals Inc.
$11
Top 3 companies account for 31.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CALA TRIO · COMIRNATY · CONTRAVE · COPAXONE · CREXONT · Cambia · Cenobamate · DUOPA · DYNASPLINT · DYSPORT · Dhivy · Duopa · Dynasplint · Dysport · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Evrysdi · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Glatiramer Acetate · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LINQ II · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · Morphabond ER · NAMZARIC · NAPRELAN · NASCOBAL · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neuromodulation Disposables and Accessories · Neuromodulation Dspsbls and Accs · Nourianz · Nuedexta · OCREVUS · ONFI · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PAXLOVID · PERCEPT PC BRAINSENSE · POMPE - DISEASE · PURIFIED CORTROPHIN GEL · Ponvory · QELBREE · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · RELEXXII · RELYVRIO · REXULTI · REYVOW · RYTARY · Radicava · Rebif · SOLIRIS · SPRIX · SUNOSI · SYNCHROMED · Soliris · Spritam · Sunosi · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · Vimpat · XARELTO · XEOMIN · XTAMPZA · XYREM · XYWAV · Xadago · Xeomin · Xyrem · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOMIG · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (77%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for optician in OH.
Geographic Context
Opticians within 10 mi
40
Per 100K population
22.2
County median income
$81,033
Nearest hospital
LICKING MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Abdelmessih is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 7% of OH peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Abdelmessih experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Abdelmessih performed 686 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abdelmessih receive payments from pharmaceutical companies?
Yes. Dr. Abdelmessih received a total of $36,913 from 99 companies across 1,557 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abdelmessih's costs compare to other opticians in Newark?
Dr. Abdelmessih's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abdelmessih) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Newark
Browse opticians in Newark ranked by procedure volume and transparency data.
Highest volume
Top Opticians in OH
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in OH
Which OH opticians receive the most from drug and device companies.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology